大分割放疗治疗非小细胞肺癌的临床研究进展  

Clinical Research Progress of High Field Radiation Therapy for Non-Small Cell Lung Cancer

作　　者：霍晓鹏 林宇[2] 

机构地区：[1]内蒙古医科大学,第一临床医学院,内蒙古 呼和浩特 [2]内蒙古医科大学附属医院,放疗科,内蒙古 呼和浩特

出　　处：《临床医学进展》2024年第6期1702-1708,共7页Advances in Clinical Medicine

摘　　要：放射治疗是恶性肿瘤的重要治疗手段之一,常规分割作为最常用的放疗模式,存在治疗总次数多、治疗周期长等缺点。随着放疗设备及技术的进步,大分割放疗已成为乳腺癌、宫颈癌等肿瘤的标准治疗方式。但大分割放疗在非小细胞肺癌中的有效性和安全性还未得到充分证实。本文对大分割放疗在非小细胞肺癌中的应用、疗效及安全性的研究进展进行综述。Radiotherapy is one of the most important treatment methods for malignant tumors. Conventional segmentation, as the most commonly used radiotherapy mode, has many disadvantages such as the total number of treatments and long treatment cycle. With the development of radiotherapy equipment and technology, large segmentation radiotherapy has become a standard treatment for breast cancer, cervical cancer and other tumors. However, the efficacy and safety of large fractionation radiotherapy in non-small cell lung cancer have not been fully demonstrated. This article reviews the application, efficacy and safety of large fractionation radiotherapy in non-small cell lung cancer.

关 键 词：大分割放疗 非小细胞肺癌 疗效 研究进展 

分 类 号：R73[医药卫生—肿瘤]